{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:28:13Z","timestamp":1776904093386,"version":"3.51.2"},"reference-count":93,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T00:00:00Z","timestamp":1274140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Travelers to tropical countries are at risk for a variety of infectious diseases. In some cases effective vaccinations are available, but for other infections chemoprophylaxis can be offered. Malaria prevention has become increasingly complex as Plasmodium species become resistant to available drugs. In certain high risk settings, antibiotics can be used to prevent leptospirosis, scrub typhus and other infections. Post-exposure prophylaxis is appropriate for selected virulent infections. In this article the evidence for chemoprophylaxis will be reviewed.<\/jats:p>","DOI":"10.3390\/ph3051561","type":"journal-article","created":{"date-parts":[[2010,5,18]],"date-time":"2010-05-18T11:03:43Z","timestamp":1274180623000},"page":"1561-1575","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Chemoprophylaxis of Tropical Infectious Diseases"],"prefix":"10.3390","volume":"3","author":[{"given":"William J. H.","family":"McBride","sequence":"first","affiliation":[{"name":"School of Medicine and Dentistry, James Cook University, Cairns Base Hospital campus, The Esplanade, Cairns, Queensland 4870, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2010,5,18]]},"reference":[{"key":"ref_1","unstructured":"Brunette, G.W., Kozarsky, P.E., Magill, A.J., and Shlim, D.R. (2009). CDC Health Information for International Travel 2010, The Yellow Book, Mosby."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrmicro974","article-title":"Passive antibody therapy for infectious diseases","volume":"2","author":"Casadevall","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157489109787236319","article-title":"Progress towards recombinant anti-infective antibodies","volume":"4","author":"Pai","year":"2009","journal-title":"Recent Pat. Antiinfect Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Jacquerioz, F.A., and Croft, A.M. (2009). Drugs for preventing malaria in travellers. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD006491.pub2"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tmaid.2009.06.004","article-title":"Malaria zoonoses","volume":"7","author":"Baird","year":"2009","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3201\/eid1405.071407","article-title":"Human Infections with Plasmodium knowlesi, the Philippines","volume":"14","author":"Luchavez","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3201\/eid1405.070863","article-title":"Naturally acquired human Plasmodium knowlesi infection, Singapore","volume":"14","author":"Ng","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3201\/eid1012.040293","article-title":"Naturally acquired Plasmodium knowlesi malaria in human, Thailand","volume":"10","author":"Jongwutiwes","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_9","first-page":"70","article-title":"Human natural infection of Plasmodium knowlesi","volume":"24","author":"Zhu","year":"2006","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"World malaria report 2008.","DOI":"10.1002\/wow3.11"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1056\/NEJMra020118","article-title":"Illness after international travel","volume":"347","author":"Ryan","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa051331","article-title":"Spectrum of disease and relation to place of exposure among ill returned travelers","volume":"354","author":"Freedman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_13","unstructured":"Mandell, G.L., Bennett, J.E., and Dolin, R. (2010). Mandell,Douglas,and Bennett's Principles and Practice of Infectious Diseases, Churchill Livingstone\/Elsevier."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1086\/320707","article-title":"Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria","volume":"183","author":"Nomura","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-3156.2006.01778.x","article-title":"Chloroquine prophylaxis against vivax malaria in pregnancy: A randomized, double-blind, placebo-controlled trial","volume":"12","author":"Villegas","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkg319","article-title":"Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties","volume":"52","author":"Warhurst","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.1999.60.533","article-title":"Malarone (atovaquone and proguanil hydrochloride): A review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group","volume":"60","author":"Looareesuwan","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/jac\/dkm337","article-title":"A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria","volume":"60","author":"Nakato","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4269\/ajtmh.2007.76.208","article-title":"Atovaquone-proguanil: Report from the CDC expert meeting on malaria chemoprophylaxis (II)","volume":"76","author":"Boggild","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMcp0803572","article-title":"Clinical practice. Malaria prevention in short-term travelers","volume":"359","author":"Freedman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4269\/ajtmh.1999.60.521","article-title":"A randomized, double-blind, placebo-controlled field trial to determine the efficacy and safety of Malarone (atovaquone\/proguanil) for the prophylaxis of malaria in Zambia","volume":"60","author":"Sukwa","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1086\/375073","article-title":"Stevens-Johnson syndrome associated with Malarone antimalarial prophylaxis","volume":"37","author":"Emberger","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/138161208784041105","article-title":"The plastid-like organelle of apicomplexan parasites as drug target","volume":"14","author":"Wiesner","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bmj.327.7423.1078","article-title":"Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: Multicentre, randomised, double blind, four arm study","volume":"327","author":"Schlagenhauf","year":"2003","journal-title":"BMJ"},{"key":"ref_25","unstructured":"Mandell, G.L., Bennett, J.E., and Dolin, R. (2010). Mandell,Douglas,and Bennett's Principles and Practice of Infectious Diseases, Churchill Livingstone\/Elsevier."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-126-12-199706150-00006","article-title":"Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial","volume":"126","author":"Ohrt","year":"1997","journal-title":"Ann. Intern. Med."},{"key":"ref_27","first-page":"872","article-title":"Mefloquine vs. doxycycline for malaria prophylaxis in intermittent exposure of Israeli Air Force aircrew in Rwanda","volume":"67","author":"Shamiss","year":"1996","journal-title":"Aviat. Space Environ. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44","author":"Vale","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1086\/324085","article-title":"Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia","volume":"33","author":"Baird","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","article-title":"Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I","volume":"75","author":"Hill","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4269\/ajtmh.1997.56.137","article-title":"Malaria in a nonimmune population after extended chloroquine or primaquine prophylaxis","volume":"56","author":"Fryauff","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.actatropica.2009.07.024","article-title":"Prevention of Plasmodium vivax malaria recurrence: Efficacy of the standard total dose of primaquine administered over 3 days","volume":"112","author":"Maestre","year":"2009","journal-title":"Acta Trop."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1475-2875-8-159","article-title":"Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations","volume":"8","author":"Lawpoolsri","year":"2009","journal-title":"Malar. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/367542","article-title":"A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum","volume":"36","author":"Hale","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/AAC.00354-09","article-title":"Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine vs. mefloquine for malaria prophylaxis in nonimmune subjects","volume":"54","author":"Nasveld","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1086\/324081","article-title":"A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria","volume":"33","author":"Shanks","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1708-8305.2006.00091.x","article-title":"Special infectious disease risks of expatriates and long-term travelers in tropical countries. Part I: Malaria","volume":"14","author":"Toovey","year":"2007","journal-title":"J. Travel. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tmaid.2008.04.005","article-title":"Pre-travel vaccination and medical prophylaxis in the pregnant traveler","volume":"6","author":"Carroll","year":"2008","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.4269\/ajtmh.2007.77.1010","article-title":"Malaria chemoprophylaxis: What do the travelers choose, and how does pretravel consultation influence their final decision","volume":"77","author":"Senn","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1708-8305.2008.00227.x","article-title":"Trends in antimalarial prescriptions in Australia 2002 to 2005","volume":"15","author":"Leggat","year":"2008","journal-title":"J. Travel. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMp058292","article-title":"The burden of illness in international travelers","volume":"354","author":"Hill","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1708-8305.2008.00299.x","article-title":"Expert review of the evidence base for prevention of travelers' diarrhea","volume":"16","author":"DuPont","year":"2009","journal-title":"J. Travel. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00508-009-1228-1","article-title":"Travellers' diarrhoea\u2014pros and cons of different prophylactic measures","volume":"121","author":"Wagner","year":"2009","journal-title":"Wien. Klin. Wochenschr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-142-10-200505170-00005","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea","volume":"142","author":"DuPont","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1086\/338640","article-title":"Drug prophylaxis for travelers' diarrhea","volume":"34","author":"Kollaritsch","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4269\/ajtmh.1990.43.608","article-title":"A comparative study of gastrointestinal infections in United States soldiers receiving doxycycline or mefloquine for malaria prophylaxis","volume":"43","author":"Arthur","year":"1990","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4269\/ajtmh.1984.33.460","article-title":"Doxycycline prophylaxis of travelers' diarrhea in Honduras, an area where resistance to doxycycline is common among enterotoxigenic Escherichia coli","volume":"33","author":"Sack","year":"1984","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Pimentel, D. (2002). Encyclopedia of Pest Management, Marcel Dekker.","DOI":"10.1201\/NOE0824706326"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5694\/j.1326-5377.1999.tb127786.x","article-title":"Scrub typhus in north Queensland","volume":"170","author":"McBride","year":"1999","journal-title":"Med. J. Aust."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4269\/ajtmh.1980.29.989","article-title":"Prevention of scrub typhus. Prophylactic administration of doxycycline in a randomized double blind trial","volume":"29","author":"Olson","year":"1980","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/infdis\/146.6.811","article-title":"Doxycycline propylaxis for human scrub typhus","volume":"146","author":"Twartz","year":"1982","journal-title":"J. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4269\/ajtmh.2006.75.955","article-title":"Scrub typhus during pregnancy and its treatment: A case series and review of the literature","volume":"75","author":"Kim","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/425008","article-title":"A comparative trial of a single dose of azithromycin vs. doxycycline for the treatment of mild scrub typhus","volume":"39","author":"Kim","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/AAC.00508-07","article-title":"Doxycycline vs. Azithromycin for treatment of Leptospirosis and Scrub Typhus","volume":"51","author":"Phimda","year":"2007","journal-title":"Antimicrob. Agents. Chemother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4269\/ajtmh.1999.61.399","article-title":"Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1996 [correction of 1966]","volume":"61","author":"Sanders","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3201\/eid0906.020751","article-title":"Leptospirosis in \"Eco-Challenge\" athletes, Malaysian Borneo, 2000","volume":"9","author":"Sejvar","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1086\/339942","article-title":"Leptospirosis, water sports, and chemoprophylaxis","volume":"34","author":"Haake","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(09)61888-2","article-title":"Philippines struggles to recover from typhoons","volume":"374","author":"McCurry","year":"2009","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/eurpub\/ckl067","article-title":"The synthetic evaluation model for analysis of flooding hazards","volume":"17","author":"Tan","year":"2007","journal-title":"Eur. J. Public Health"},{"key":"ref_60","first-page":"125","article-title":"Brief report: Leptospirosis after flooding of a university campus\u2014Hawaii, 2004","volume":"55","author":"Park","year":"2006","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00001432-200110000-00005","article-title":"Leptospirosis","volume":"14","author":"Vinetz","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/425001","article-title":"An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis","volume":"39","author":"Suputtamongkol","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1128\/AAC.01467-05","article-title":"Efficacy of macrolides and telithromycin against leptospirosis in a hamster model","volume":"50","author":"Moon","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/pgmj.64.749.236","article-title":"Failure of penicillin prophylaxis in laboratory acquired leptospirosis","volume":"64","author":"Gilks","year":"1988","journal-title":"Postgrad. Med. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM198402233100805","article-title":"An efficacy trial of doxycycline chemoprophylaxis against leptospirosis","volume":"310","author":"Takafuji","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1590\/S0036-46651998000100012","article-title":"Use of doxycycline for leptospirosis after high-risk exposure in Sao Paulo, Brazil","volume":"40","author":"Gonsalez","year":"1998","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0924-8579(99)00134-X","article-title":"Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area","volume":"13","author":"Sehgal","year":"2000","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Brett-Major, D.M., and Lipnick, R.J. (2009). Antibiotic prophylaxis for leptospirosis. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD007342.pub2"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5694\/j.1326-5377.2002.tb04736.x","article-title":"9: Infections in the returned traveller","volume":"177","author":"Looke","year":"2002","journal-title":"Med. J. Aust."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"729","DOI":"10.4269\/ajtmh.2008.79.729","article-title":"Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008","volume":"79","author":"Nicolls","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_71","first-page":"724","article-title":"Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: Its in vivo effect on the biochemical metabolism of the Asian schistosome","volume":"31","author":"Shuhua","year":"2000","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0140-6736(00)02114-0","article-title":"Oral artemether for prevention of Schistosoma mansoni infection: Randomised controlled trial","volume":"355","author":"Utzinger","year":"2000","journal-title":"Lancet"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4269\/ajtmh.2005.72.443","article-title":"Prevention of leprosy using rifampicin as chemoprophylaxis","volume":"72","author":"Bakker","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1016\/j.vaccine.2009.09.054","article-title":"Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy prevention","volume":"27","author":"Schuring","year":"2009","journal-title":"Vaccine"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","article-title":"Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: Cluster randomised controlled trial","volume":"336","author":"Moet","year":"2008","journal-title":"BMJ"},{"key":"ref_76","first-page":"S33","article-title":"Chemoprophylaxis of leprosy in the southern Marquesas with a single 25 mg\/kg dose of rifampicin: Results after 10 years","volume":"71","author":"Nguyen","year":"2000","journal-title":"Lepr. Rev."},{"key":"ref_77","first-page":"S21","article-title":"Leprosy chemoprophylaxis in Micronesia","volume":"71","author":"Diletto","year":"2000","journal-title":"Lepr. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Okwundu, C.I., and Okoromah, C.A. (2009). Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst. Rev.","DOI":"10.1002\/14651858.CD007189.pub2"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1371\/journal.pctr.0020027","article-title":"Tenofovir disoproxil fumarate for prevention of HIV infection in women: A phase 2, double-blind, randomized, placebo-controlled trial","volume":"2","author":"Peterson","year":"2007","journal-title":"PLoS Clin. Trials"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","article-title":"Melioidosis: Epidemiology, pathophysiology, and management","volume":"18","author":"Cheng","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jac\/dkm527","article-title":"Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin\/clavulanic acid and co-trimoxazole","volume":"61","author":"Sivalingam","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.3201\/eid1511.090038","article-title":"Imported melioidosis, Israel, 2008","volume":"15","author":"Cahn","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_83","first-page":"988","article-title":"Laboratory exposure to Burkholderia pseudomallei\u2014Los Angeles, California, 2003","volume":"53","author":"Currie","year":"2004","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1086\/421024","article-title":"Prevention of laboratory-acquired brucellosis","volume":"38","author":"Robichaud","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3201\/eid1108.041197","article-title":"Laboratory exposures to brucellae and implications for bioterrorism","volume":"11","author":"Yagupsky","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1001\/jama.283.17.2281","article-title":"Plague as a biological weapon: Medical and public health management. Working Group on Civilian Biodefense","volume":"283","author":"Inglesby","year":"2000","journal-title":"JAMA"},{"key":"ref_87","unstructured":"(2001). CDC Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001. MMWR Morb. Mortal. Wkly. Rep., 50, 889\u2013893."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ana.1062","article-title":"Treatment of acute Nipah encephalitis with ribavirin","volume":"49","author":"Chong","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1099\/vir.0.017269-0","article-title":"Combined chloroquine and ribavirin treatment does not prevent death in a hamster model of Nipah and Hendra virus infection","volume":"91","author":"Freiberg","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3201\/eid1602.090552","article-title":"Human hEndra virus encephalitis associated with equine outbreak, Australia, 2008","volume":"16","author":"Playford","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1745-6673-4-29","article-title":"Recommendation for post-exposure prophylaxis after potential exposure to herpes b virus in Germany","volume":"4","author":"Reme","year":"2009","journal-title":"J. Occup. Med. Toxicol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3201\/eid0808.010467","article-title":"Human exposure to herpesvirus B-seropositive macaques, Bali, Indonesia","volume":"8","author":"Engel","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1086\/344754","article-title":"Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1)","volume":"35","author":"Cohen","year":"2002","journal-title":"Clin. Infect. Dis."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/5\/1561\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:02:28Z","timestamp":1760220148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/3\/5\/1561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,18]]},"references-count":93,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,5]]}},"alternative-id":["ph3051561"],"URL":"https:\/\/doi.org\/10.3390\/ph3051561","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,18]]}}}